Reviewnpj metabolic health and disease2026
Muscle mass as a resilence factor for endothelial health in obesity.
Review in npj metabolic health and disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Obesity remains the most common risk factor for cardiovascular disease in Western nations. While considerable effort has focused on identifying risk factors, which contribute to the increase incidence of complications and disease, an emerging concept is the existence of resilience factors, which mitigate disease. An important resilience factor gaining increased appreciation is the amount of skeletal muscle mass. In this review, we will explore how obesity increases the most-identified vascular component of metabolic vascular disease - endothelial dysfunction-how increases in muscle mass may protect vascular function in the obese population. This review advances the concept the obesity is less a disease of body mass than body composition which is reflected in the degree of negative vascular outcomes and may be of increased relevance in consideration of therapies that promote loss of muscle mass while reducing overall body size.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.